122 related articles for article (PubMed ID: 7573606)
1. Lithium or desipramine augmentation of fluoxetine treatment.
Nelson JC; Price LH
Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
[No Abstract] [Full Text] [Related]
2. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
Fava M; Rosenbaum JF; McGrath PJ; Stewart JW; Amsterdam JD; Quitkin FM
Am J Psychiatry; 1994 Sep; 151(9):1372-4. PubMed ID: 8067495
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response.
Eisen A
Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636
[No Abstract] [Full Text] [Related]
4. Sequence of drug administration in lithium augmentation: a case study.
Price LH; Delgado PL; Charney DS; Heninger GR
J Clin Psychiatry; 1988 Apr; 49(4):161-2. PubMed ID: 3356674
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine and desipramine in major depressive disorder.
Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
[TBL] [Abstract][Full Text] [Related]
6. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.
Fontaine R; Ontiveros A; Elie R; Vézina M
Biol Psychiatry; 1991 May; 29(9):946-8. PubMed ID: 1904782
[No Abstract] [Full Text] [Related]
7. Possible synergism between fluoxetine and lithium in refractory depression.
Pope HG; McElroy SL; Nixon RA
Am J Psychiatry; 1988 Oct; 145(10):1292-4. PubMed ID: 3262313
[TBL] [Abstract][Full Text] [Related]
8. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.
Perlis RH; Alpert J; Nierenberg AA; Mischoulon D; Yeung A; Rosenbaum JF; Fava M
Acta Psychiatr Scand; 2003 Dec; 108(6):432-8. PubMed ID: 14616224
[TBL] [Abstract][Full Text] [Related]
9. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine.
Suckow RF; Roose SP; Cooper TB
Biol Psychiatry; 1992 Jan; 31(2):200-4. PubMed ID: 1737080
[No Abstract] [Full Text] [Related]
11. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression.
Nelson JC; Mazure CM; Bowers MB; Jatlow PI
Arch Gen Psychiatry; 1991 Apr; 48(4):303-7. PubMed ID: 2009031
[TBL] [Abstract][Full Text] [Related]
12. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients.
Austin LS; Arana GW; Melvin JA
J Clin Psychiatry; 1990 Aug; 51(8):344-5. PubMed ID: 2380160
[TBL] [Abstract][Full Text] [Related]
13. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine inhibits desipramine metabolism.
Wilens TE; Biederman J; Baldessarini RJ; McDermott SP; Puopolo PR; Flood JG
Arch Gen Psychiatry; 1992 Sep; 49(9):752. PubMed ID: 1514882
[No Abstract] [Full Text] [Related]
15. Elevated tricyclic antidepressant plasma concentrations associated with fluoxetine: two case reports.
Michals M; Stanley DA; Crismon ML; Barrow NE
J Neuropsychiatry Clin Neurosci; 1990; 2(4):466-7. PubMed ID: 2136405
[No Abstract] [Full Text] [Related]
16. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
[TBL] [Abstract][Full Text] [Related]
17. Refractory depression: the addition of lithium to fluoxetine or desipramine.
Ontiveros A; Fontaine R; Elie R
Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
[TBL] [Abstract][Full Text] [Related]
18. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report.
Howland RH
Can J Psychiatry; 1991 Mar; 36(2):154-5. PubMed ID: 1904303
[No Abstract] [Full Text] [Related]
19. Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions.
Hawley CJ; Roberts AG; Baldwin DS
Int Clin Psychopharmacol; 1994; 9(1):31-3. PubMed ID: 8195580
[TBL] [Abstract][Full Text] [Related]
20. Identifying depression secondary to lithium-induced hypothyroidism.
Sternbach HA; Pottash AL; Extein I; Gold MS
Psychosomatics; 1984 Nov; 25(11):864-6. PubMed ID: 6505132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
